| Tag | Content |
|---|
EnhancerAtlas ID | HS105-02912 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr1:54803250-54804820 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| E2F6 | MA0471.1 | chr1:54804129-54804140 | GCTTCCCGCCC | - | 6.02 | | ELF1 | MA0473.2 | chr1:54803761-54803773 | AAACCGGAAGTG | + | 6.27 | | ELF4 | MA0641.1 | chr1:54803761-54803773 | AAACCGGAAGTG | + | 6.27 | | ELK1 | MA0028.2 | chr1:54803763-54803773 | ACCGGAAGTG | + | 6.02 | | ELK4 | MA0076.2 | chr1:54803763-54803774 | ACCGGAAGTGC | - | 6.02 | | ERG | MA0474.2 | chr1:54803763-54803773 | ACCGGAAGTG | + | 6.02 | | ETS1 | MA0098.3 | chr1:54803763-54803773 | ACCGGAAGTG | + | 6.02 | | FEV | MA0156.2 | chr1:54803763-54803773 | ACCGGAAGTG | + | 6.02 | | FLI1 | MA0475.2 | chr1:54803763-54803773 | ACCGGAAGTG | + | 6.02 | | Foxd3 | MA0041.1 | chr1:54803959-54803971 | GAATGTTTATTT | + | 6.74 | | MNX1 | MA0707.1 | chr1:54804544-54804554 | TTTAATTACC | - | 6.02 | | NFAT5 | MA0606.1 | chr1:54804196-54804206 | AATGGAAAAT | - | 6.02 | | NFATC1 | MA0624.1 | chr1:54804196-54804206 | AATGGAAAAT | - | 6.02 | | NFATC3 | MA0625.1 | chr1:54804196-54804206 | AATGGAAAAT | - | 6.02 | | Nr2f6(var.2) | MA0728.1 | chr1:54803387-54803402 | TGAACTCCTGACCTC | - | 6.22 |
|
| | Number of super-enhancer constituents: 8 | ID | Coordinate | Tissue/cell |
| SE_07802 | chr1:54804140-54809587 | Brain_Inferior_Temporal_Lobe | | SE_24449 | chr1:54803720-54804070 | Colon_Crypt_2 | | SE_29698 | chr1:54803479-54805037 | Fetal_Muscle | | SE_31383 | chr1:54800045-54804738 | Gastric | | SE_33414 | chr1:54803684-54812351 | H2171 | | SE_41605 | chr1:54803705-54803983 | LNCaP | | SE_63284 | chr1:54754699-54809827 | NCI-H82 | | SE_66951 | chr1:54803684-54812351 | H2171 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I054329 | chr1 | 54794861 | 54804767 |
|
Enhancer Sequence | ACCTCCCTCC GTCTCCCGGG TTCCAGCGAT TCCCTTGCCT CATGAGTAGC TGGGACTACA 60
GGCATCCACC ACCACACCCG ACTAATTTTT GTATTTTTAG TAGAGACAGA GTTTCACCAT 120
GTTGGCCAGG CTGGTCTTGA ACTCCTGACC TCAGGTGATC ACCTGCCTTG GCCTCCCAAA 180
GGGCTGGGAT GATAGGCGTG GGCCACCATG CCCGGCCTCC TCAAACTTTT TGAAGACAGT 240
GAGTTTTTTG GGCATAAAAA ATAAAATCTG GCTGAGCATG GTGGCTCACG TCTGTAACCC 300
CAAAACTCTG GGAGGCCAAG GCAGGGGGAT CACTTGAGCC CAGTAGTTCA AGACCAACCT 360
GGACAACATA ATGAGACCCC CATCTCTATC TTTTAATTTA TTTTTGAAAA ATAATGAGAA 420
TAAAGTCCCA GGCCGACTGA GAAATAAAAT GAGATATAAT GATTGTAACC ATCCATGACA 480
TCATGTGTGT ATATTACACT CAACAGCAAC TAAACCGGAA GTGCTTCTCC AGTTTGTGAA 540
GCCAGCTTCT GCACTCACTG CCTGCTCCAG GAAGTTGCCT GTGACTGCCC CTGTGGTCCA 600
GGTGTCCCTC TCCTGTGTTC ACAGCCTCGG TGCCCCTACT GCAATGGGGC TGCATAGCCG 660
GCACCTACGG CAGGGCGGGC TGATATGCTT GCCTTGCATA TGCTAAAGCG AATGTTTATT 720
TTTCCATTTC CCCAACTAGA CTGTAAAATC CTTGAGGGAC AATACCTTAT TCTACTTTAC 780
TTTGCAAATA CCTGGGAAAA GATCTAGCAT GTATCTCACA CTGAAAAACC ATCTGTTGAA 840
TAAATAACCA AAGTGATGAG CACATGGCTG CCCGCCTATG CTTCCCGCCC TCTCACTCCC 900
GACCCCTAAC CCCACTTTCT CCACCCGCTA GAAGCATTCT GAAGAGAATG GAAAATCTCA 960
GCCAACTATT CAGGGTAACT GTCCGGTCAC TCTGCGTCCA TTTGCCTTTA CGGCAATATA 1020
TATACTAAAG GGTATGAGCT CAAGTTTCCA TACATACCCA GGCAGCCAAG GGAGTTCTCT 1080
CTTCCCAGCC GAGGCTAAAC AGGGACCCAA CCACAAGCAT CCAGTAATTC TGAATATGAC 1140
GTGAACAACG TAAAAATAGC TCCTGTATCT CTTTGCCCCC ACCCTTCTCC CCAACAACAC 1200
AAAGGGCAGA AGAGAGTGAC ACCCCTAACA AACAGCCCCA GCCTCCTACA TCTGGACCAG 1260
CTGCTGTGAG CCAACAGGGT ATTCTAAATT ATACTTTAAT TACCATAATT TTTCACAGGT 1320
ACCTGAAACC AGATCATGAC GACGGTGCAA GAAATCCCCA AATAGGATGC ACGAGGTCCA 1380
AGTTAAAGCT AGTCTTCTAA ACACACACCT TTTCTCACAT GCCTTTTATT TCATGTAGCA 1440
CTTTACAGTC TGCAGAGTGC TTTCATGGGC CTTCTCTCTC CCACAGGCTC TGGATTAAGA 1500
CAACATGGTT CAATTCCAGC CTCCAAAGTA TCCTGCCCTC TCCAGAGACC CTTCACCTAT 1560
CACCATTTGG 1570
|
